vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Construction Partners, Inc. (ROAD). Click either name above to swap in a different company.

Construction Partners, Inc. is the larger business by last-quarter revenue ($809.5M vs $487.7M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). Construction Partners, Inc. runs the higher net margin — 2.1% vs -10.1%, a 12.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 44.1%). Construction Partners, Inc. produced more free cash flow last quarter ($47.1M vs $-69.0M). Over the past eight quarters, Construction Partners, Inc.'s revenue compounded faster (47.6% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Alexander Construction Company was a Palm Springs, California, residential development company that built over 2,200 houses in the Coachella Valley of Riverside County, California, between 1955 and 1965.

CLOV vs ROAD — Head-to-Head

Bigger by revenue
ROAD
ROAD
1.7× larger
ROAD
$809.5M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+0.6% gap
CLOV
44.7%
44.1%
ROAD
Higher net margin
ROAD
ROAD
12.2% more per $
ROAD
2.1%
-10.1%
CLOV
More free cash flow
ROAD
ROAD
$116.1M more FCF
ROAD
$47.1M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
ROAD
ROAD
Annualised
ROAD
47.6%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
ROAD
ROAD
Revenue
$487.7M
$809.5M
Net Profit
$-49.3M
$17.2M
Gross Margin
15.0%
Operating Margin
-10.1%
6.2%
Net Margin
-10.1%
2.1%
Revenue YoY
44.7%
44.1%
Net Profit YoY
-123.2%
663.9%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ROAD
ROAD
Q4 25
$487.7M
$809.5M
Q3 25
$496.6M
$899.8M
Q2 25
$477.6M
$779.3M
Q1 25
$462.3M
$571.6M
Q4 24
$337.0M
$561.6M
Q3 24
$331.0M
$538.2M
Q2 24
$356.3M
$517.8M
Q1 24
$346.9M
$371.4M
Net Profit
CLOV
CLOV
ROAD
ROAD
Q4 25
$-49.3M
$17.2M
Q3 25
$-24.4M
$56.6M
Q2 25
$-10.6M
$44.0M
Q1 25
$-1.3M
$4.2M
Q4 24
$-22.1M
$-3.1M
Q3 24
$-9.2M
$29.3M
Q2 24
$7.4M
$30.9M
Q1 24
$-19.2M
$-1.1M
Gross Margin
CLOV
CLOV
ROAD
ROAD
Q4 25
15.0%
Q3 25
17.7%
Q2 25
16.9%
Q1 25
12.5%
Q4 24
13.6%
Q3 24
24.5%
15.6%
Q2 24
30.3%
16.1%
Q1 24
23.6%
10.4%
Operating Margin
CLOV
CLOV
ROAD
ROAD
Q4 25
-10.1%
6.2%
Q3 25
-4.9%
11.2%
Q2 25
-2.2%
10.6%
Q1 25
-0.3%
4.8%
Q4 24
-6.4%
2.5%
Q3 24
-2.7%
8.5%
Q2 24
2.0%
8.8%
Q1 24
-6.5%
0.8%
Net Margin
CLOV
CLOV
ROAD
ROAD
Q4 25
-10.1%
2.1%
Q3 25
-4.9%
6.3%
Q2 25
-2.2%
5.7%
Q1 25
-0.3%
0.7%
Q4 24
-6.6%
-0.5%
Q3 24
-2.8%
5.4%
Q2 24
2.1%
6.0%
Q1 24
-5.5%
-0.3%
EPS (diluted)
CLOV
CLOV
ROAD
ROAD
Q4 25
$0.31
Q3 25
$1.03
Q2 25
$0.79
Q1 25
$0.08
Q4 24
$-0.06
Q3 24
$0.55
Q2 24
$0.59
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ROAD
ROAD
Cash + ST InvestmentsLiquidity on hand
$78.3M
$104.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$969.1M
Total Assets
$541.0M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ROAD
ROAD
Q4 25
$78.3M
$104.1M
Q3 25
$156.1M
Q2 25
$114.3M
Q1 25
$101.9M
Q4 24
$194.5M
$132.5M
Q3 24
$288.0M
$74.7M
Q2 24
$254.8M
$56.3M
Q1 24
$208.3M
$48.0M
Total Debt
CLOV
CLOV
ROAD
ROAD
Q4 25
Q3 25
$1.6B
Q2 25
Q1 25
Q4 24
Q3 24
$515.0M
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
ROAD
ROAD
Q4 25
$308.7M
$969.1M
Q3 25
$340.9M
$912.0M
Q2 25
$344.2M
$853.3M
Q1 25
$336.1M
$807.9M
Q4 24
$341.1M
$811.1M
Q3 24
$342.2M
$573.7M
Q2 24
$324.9M
$552.9M
Q1 24
$292.5M
$525.0M
Total Assets
CLOV
CLOV
ROAD
ROAD
Q4 25
$541.0M
$3.4B
Q3 25
$559.7M
$3.2B
Q2 25
$575.0M
$2.9B
Q1 25
$583.7M
$2.8B
Q4 24
$580.7M
$2.6B
Q3 24
$653.0M
$1.5B
Q2 24
$674.2M
$1.4B
Q1 24
$671.8M
$1.3B
Debt / Equity
CLOV
CLOV
ROAD
ROAD
Q4 25
Q3 25
1.78×
Q2 25
Q1 25
Q4 24
Q3 24
0.90×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ROAD
ROAD
Operating Cash FlowLast quarter
$-66.9M
$82.6M
Free Cash FlowOCF − Capex
$-69.0M
$47.1M
FCF MarginFCF / Revenue
-14.1%
5.8%
Capex IntensityCapex / Revenue
0.4%
4.4%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$186.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ROAD
ROAD
Q4 25
$-66.9M
$82.6M
Q3 25
$12.1M
$112.0M
Q2 25
$5.4M
$83.0M
Q1 25
$-16.3M
$55.6M
Q4 24
$34.8M
$40.7M
Q3 24
$50.0M
$95.9M
Q2 24
$44.8M
$34.6M
Q1 24
$25.9M
$18.2M
Free Cash Flow
CLOV
CLOV
ROAD
ROAD
Q4 25
$-69.0M
$47.1M
Q3 25
$11.4M
$78.9M
Q2 25
$4.8M
$46.4M
Q1 25
$-16.5M
$14.2M
Q4 24
$33.3M
$13.8M
Q3 24
$49.6M
$78.4M
Q2 24
$44.4M
$19.7M
Q1 24
$25.5M
$-10.6M
FCF Margin
CLOV
CLOV
ROAD
ROAD
Q4 25
-14.1%
5.8%
Q3 25
2.3%
8.8%
Q2 25
1.0%
5.9%
Q1 25
-3.6%
2.5%
Q4 24
9.9%
2.5%
Q3 24
15.0%
14.6%
Q2 24
12.5%
3.8%
Q1 24
7.3%
-2.8%
Capex Intensity
CLOV
CLOV
ROAD
ROAD
Q4 25
0.4%
4.4%
Q3 25
0.1%
3.7%
Q2 25
0.1%
4.7%
Q1 25
0.0%
7.2%
Q4 24
0.5%
4.8%
Q3 24
0.1%
3.3%
Q2 24
0.1%
2.9%
Q1 24
0.1%
7.7%
Cash Conversion
CLOV
CLOV
ROAD
ROAD
Q4 25
4.80×
Q3 25
1.98×
Q2 25
1.88×
Q1 25
13.20×
Q4 24
Q3 24
3.27×
Q2 24
6.04×
1.12×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons